Filing Flows › Medicinova (MNOV) › Q3 2025
Medicinova (MNOV) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 12, 2025
Medicinova (MNOV) reported revenue of $123K for the third quarter 2025 (Q3 2025) and -8% from the quarter before.
Medicinova, Q3 2025: revenue $123K, net loss $3.1M, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $123K | -8% | — |
| Operating profit | −$3.4M | — | — |
| Net earnings | −$3.1M | — | — |
| Operating cash flow | −$1.7M | — | — |
What changed
Revenue was $123K in Q3 2025, down 8% from the previous quarter.
Operating costs exceeded revenue by $3.4M, an operating margin of -2741.7%. The quarter ended with a net loss of $3.1M, narrower than the previous quarter's $3.3M loss.
Operating cash flow was −$1.7M. Non-cash charges added back $5K of depreciation and amortization and $158K of share-based compensation. Working capital and other items added $1.2M. Capital expenditures of $3K exceeded it, leaving free cash flow of −$1.7M.
Questions
What was Medicinova's revenue in the third quarter 2025?
Medicinova (MNOV) reported revenue of $123K for the third quarter 2025 (Q3 2025) and -8% from the quarter before.
Source: Medicinova 10-Q on SEC EDGAR.